Market Outlook

By 2035, the U.S. Cataract Surgery Devices Market is projected to reach approximately USD 6.04 billion, expanding at a CAGR of 7.76% during the forecast period 2026–2035. The market is estimated at USD 2.86 billion in 2025, with historical analysis covering 2021–2024. Values in this report are expressed in USD billions.

The U.S. cataract surgery devices industry represents one of the most procedure-resilient and recurring segments of ophthalmic medtech. Cataract extraction is among the most frequently performed surgical procedures in the country, with approximately 4 million cataract surgeries performed annually in the United States. Procedure demand is supported by an expanding elderly population, longer life expectancy, rising expectations for postoperative visual independence, growing diagnosis rates, and a well-established network of ophthalmologists and ambulatory surgery centers.

Demographics provide an unusually durable demand foundation. The U.S. population aged 65 years and older reached approximately 61.2 million in 2024, representing about 18% of the population, and this age cohort is growing considerably faster than the overall population. Cataract incidence rises sharply with age, meaning demographic expansion translates directly into higher screening, surgical consultation, intraocular lens implantation, and postoperative care volumes. Existing epidemiological estimates indicate that more than 20 million Americans aged 40 years and older have cataracts in one or both eyes.

The commercial opportunity extends far beyond conventional monofocal intraocular lenses. The market increasingly includes premium presbyopia-correcting IOLs, toric lenses, extended-depth-of-focus technologies, light-adjustable lenses, advanced phacoemulsification consoles, active fluidics, femtosecond laser systems, ophthalmic viscosurgical devices, procedure packs, injectors, surgical instrumentation, image-guided planning technologies, and digital workflow platforms.

Historical market value increased from approximately USD 2.07 billion in 2021 to USD 2.66 billion in 2024. Growth during this period reflected normalization of elective surgical volumes following pandemic-related disruptions, increasing premium-IOL penetration, replacement of aging phacoemulsification consoles, consolidation of cataract procedures into high-throughput ambulatory surgery centers, and stronger patient interest in spectacle independence.

The market reached approximately USD 2.86 billion in 2025, supported by continued surgical-volume growth and an important capital-equipment replacement cycle. New-generation cataract platforms are competing on fluidics stability, ultrasound efficiency, lower energy delivery, automated setup, connectivity, consumable economics, and operating-room throughput rather than phaco power alone.

From 2026 through 2035, revenue growth is expected to increasingly outpace procedure-volume growth because the value per cataract case is rising. Premium lenses, toric correction, EDOF optics, refractive planning, femtosecond laser use in selected cases, digital biometry integration, and advanced disposable systems are increasing revenue captured per surgical episode. Consequently, the U.S. cataract surgery devices market is transitioning from a predominantly volume-driven market to a hybrid volume-and-premiumization model.

 

Introduction

According to the U.S. Cataract Surgery Devices Market Report, cataract surgery sits at the intersection of medical necessity, elective refractive enhancement, outpatient surgical efficiency, and demographic expansion. Few medical-device markets combine recurring procedure volumes with such a high proportion of planned outpatient surgery and such meaningful potential for patients to select premium technologies beyond the reimbursed standard of care.

The standard U.S. cataract procedure typically involves small-incision phacoemulsification followed by implantation of a foldable intraocular lens. While the fundamental procedure is highly standardized, substantial technological differentiation exists around energy delivery, fluidics, incision management, capsular access, IOL design, astigmatism correction, presbyopia management, surgical guidance, and workflow automation.

This creates several distinct revenue pools. Conventional monofocal IOLs generate substantial recurring unit demand. Premium IOLs capture significantly higher value per implant. Surgical consoles generate capital-equipment revenue and create long-term pull-through demand for proprietary cassettes, tubing, handpieces, tips, packs, and other disposables. Femtosecond laser systems add a further capital and procedural component. Ophthalmic viscosurgical devices, injectors, knives, forceps, capsular devices, irrigation and aspiration products, and disposable packs create additional recurring revenue around every case.

Cataract surgery is particularly important to U.S. ambulatory surgery center economics because it combines short procedure duration, relatively predictable postoperative pathways, high case repeatability, and limited inpatient resource requirements. Efficient cataract centers may perform numerous cases during a single operating session, making minutes of room turnover, setup time, surgeon transition time, and equipment downtime commercially meaningful.

Hospital procurement behavior therefore differs from that seen in many high-acuity medical-device categories. Cataract buyers frequently evaluate an integrated procedural ecosystem: console price, service contract, disposable cost per case, IOL economics, surgeon preference, staff familiarity, pack standardization, inventory requirements, lens-loading workflow, service reliability, and compatibility with diagnostic and refractive-planning systems.

Reimbursement also creates a distinctive dual-market structure. Medicare and other payers support medically necessary cataract extraction and conventional IOL implantation, while U.S. Medicare policy permits beneficiaries to assume additional costs associated with certain non-covered presbyopia-correcting and astigmatism-correcting functionality. This structure supports an important premium cataract economy in which clinical necessity establishes the procedure base and consumer willingness to pay can expand revenue per procedure.

Between 2026 and 2035, the strategic question for manufacturers will therefore not simply be how many cataract procedures are performed. The more important questions will be which companies control the highest-value lens categories, which surgical platforms become the preferred installed base, how rapidly premium-IOL penetration expands, and which technologies measurably improve refractive predictability and operating-room productivity.

 

Key Market Drivers: What’s Fueling the U.S. Cataract Surgery Devices Market Boom?

The most durable market driver is demographic aging. The U.S. population aged 65 and older exceeded 61 million people in 2024, and this population continues to increase as large demographic cohorts enter cataract-prone age ranges. Cataract prevalence rises substantially after age 60 and becomes especially high in patients approaching their eighth decade of life. An expanding elderly population therefore supports not only additional cataract diagnoses but also bilateral procedures, sequential-eye surgery, complex cases, and associated premium-lens opportunities.

The second driver is the exceptional underlying procedure base. Close to 4 million cataract surgeries are performed annually in the U.S., creating one of the largest recurring consumable opportunities in ophthalmology. Every procedure typically requires an IOL as well as multiple disposable or single-use products. Even modest increases in procedure volume can therefore translate into substantial incremental device demand.

A third driver is increasing premiumization of intraocular lenses. Traditional monofocal lenses remain the procedural baseline, but patient expectations have moved beyond simple restoration of distance vision. Retirees increasingly remain professionally active, drive at night, use digital devices extensively, participate in sports, and expect functional near and intermediate vision. This has expanded interest in toric, multifocal, trifocal, EDOF, enhanced monofocal, and adjustable-lens technologies.

Premium cataract economics are particularly attractive to device manufacturers because revenue growth can exceed surgical-volume growth. Each incremental shift from a conventional lens toward a premium optic can create a disproportionately larger increase in market value. Manufacturers are consequently investing heavily in optical design, halo and glare reduction, contrast sensitivity, astigmatic correction, refractive tolerance, injector technology, and patient-selection tools.

The fourth driver is migration toward ambulatory surgery centers. Cataract extraction is highly compatible with the ASC model because cases are usually elective, short-duration, minimally invasive, and performed under local or monitored anesthesia. Ophthalmology-specific ASCs and physician-affiliated surgical centers increasingly optimize around high-volume cataract workflows. This supports demand for compact consoles, fast setup, predictable fluidics, standardized disposable packs, reliable injectors, and technologies that reduce room turnaround.

A fifth driver is capital-equipment replacement. Phacoemulsification platforms have long installed lives, but a new replacement cycle is developing as manufacturers introduce equipment emphasizing active fluidics, more responsive vacuum management, lower ultrasound energy, improved anterior chamber stability, digital connectivity, intelligent service functions, automated priming, and simplified user interfaces.

Equipment vendors benefit from a classic installed-base business model. Winning a console placement can influence years of associated cassette, tubing, handpiece, pack, and disposable purchasing. This makes equipment competition strategically important even where capital-system revenue itself represents a smaller portion of the total market.

The sixth driver is U.S. reimbursement architecture. Medicare coverage preserves broad access to medically necessary cataract surgery, while established policies permit patients to pay additional amounts for certain premium refractive functions. This arrangement creates a two-tier value opportunity: a stable reimbursed procedural foundation and an incremental consumer-financed premium market.

Finally, the increasing emphasis on refractive outcomes is changing purchasing behavior. Surgeons are being evaluated not simply on cataract removal but on postoperative visual quality and spectacle independence. Accurate biometry, toric alignment, posterior corneal astigmatism assessment, lens-constant optimization, intraoperative guidance, and postoperative adjustment are therefore becoming increasingly important components of cataract surgery economics.

 

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in the U.S. cataract surgery devices market is shifting from isolated device improvement toward integrated procedural optimization. Leading manufacturers increasingly compete across preoperative measurement, surgical equipment, IOL selection, lens delivery, intraoperative guidance, postoperative refractive performance, data analysis, and service support.

Phacoemulsification innovation remains an important competitive battleground. New-generation platforms are designed to achieve efficient lens removal while maintaining anterior chamber stability and reducing unnecessary energy delivery. Active fluidics, high-speed pressure sensing, automated vacuum control, improved aspiration performance, and enhanced software algorithms allow surgeons to manage both routine cataracts and denser lenses with greater predictability.

The transition from legacy platforms is commercially significant. New U.S. cataract equipment launched during 2024–2025 has emphasized faster nucleus removal, lower energy delivery, improved setup and teardown efficiency, predictive service capabilities, and integrated cataract-retina functionality. These features directly address high-volume ASC economics, where saved minutes can support additional cases without adding operating rooms.

IOL innovation is advancing even more rapidly. Cataract lenses increasingly compete on quality of vision rather than simple optical power. Modern designs target full-range vision, intermediate-distance performance, astigmatism correction, contrast preservation, tolerance to residual refractive error, and reduction of photic phenomena such as halos and glare.

The competitive cycle intensified further with recent U.S. commercialization of advanced full-range and EDOF lenses. New premium IOLs are being positioned around clinically meaningful trade-offs between spectacle independence and visual disturbances. In 2026, the U.S. market gained another important EDOF lens approval designed to maintain contrast performance closer to an aspheric monofocal while extending functional vision.

Adjustable optics represent another important innovation category. Light-adjustable IOL technology allows refractive power to be modified after implantation, addressing one of cataract surgery’s most persistent limitations: the inability to fully predict the eye’s final postoperative refractive result before surgery. Although currently a premium niche, postoperative adjustability could reshape cataract expectations among highly demanding patients and surgeons.

Image-guided surgery is also becoming more influential. Modern cataract workflows increasingly connect optical biometry, corneal topography, toric calculation, digital marking, surgical planning, microscopes, and postoperative analytics. The commercial advantage increasingly belongs to manufacturers capable of creating interoperable or vertically integrated ecosystems rather than selling standalone devices.

Femtosecond laser cataract surgery remains a meaningful but selective technology segment. Adoption has been constrained by capital cost, procedure time, facility workflow, and limited payer coverage for purely cataract-removal functions. However, femtosecond systems remain relevant in premium refractive cataract programs where surgeons value automated capsulotomy, lens fragmentation, arcuate incisions, and differentiated patient experiences.

Another major innovation theme is waste reduction and procedure-pack optimization. With millions of cataract procedures performed each year, small changes in unused medication, packaging, disposable content, and pack customization can have large aggregate effects. High-volume ASCs increasingly expect suppliers to help optimize per-case cost, reduce unused items, and simplify inventory while maintaining sterility and clinical performance.

 

Segmentation Insights

The U.S. Cataract Surgery Devices Market is segmented on the basis of product type, surgery type, technology, end user, and region.

 

By Product Type

Intraocular Lenses

Intraocular lenses represent the largest product category and are estimated to account for approximately USD 1.62 billion of U.S. market value in 2025. Their dominance reflects essentially one implant opportunity for each cataract procedure and the substantial price differential between standard and premium optics.

Monofocal IOLs remain the highest-volume subsegment and constitute the foundation of reimbursed cataract care. Their long clinical history, predictable performance, broad insurance coverage, and lower acquisition cost support continued use across Medicare-heavy facilities.

Toric IOLs form a higher-value segment because they address pre-existing corneal astigmatism at the time of cataract surgery. Adoption is supported by growing patient awareness and the ability of modern biometry and image-guidance systems to improve axis planning.

Multifocal and trifocal IOLs address distance, intermediate, and near vision and are important revenue contributors within premium cataract programs. Growth is being influenced by improved optical designs intended to provide broader spectacle independence with fewer visual side effects.

Extended-depth-of-focus IOLs are among the fastest-growing premium lens categories. These products seek to extend functional range while maintaining visual quality closer to monofocal performance. New U.S. product introductions are intensifying competition around contrast sensitivity, dysphotopsia, and intermediate vision.

Light-adjustable and other advanced customizable IOLs remain smaller by volume but represent one of the highest-value lens segments. Their ability to refine postoperative refractive outcomes is particularly relevant to patients with previous refractive surgery or unusually demanding visual expectations.

Phacoemulsification Systems and Handpieces

Phacoemulsification systems and associated products represent an estimated USD 0.51 billion market in 2025. The segment includes consoles, handpieces, phaco tips, irrigation and aspiration components, cassettes, tubing, fluid-management products, and related disposables.

Capital replacement is being driven by active-fluidics technology, enhanced chamber stability, lower-energy strategies, faster setup, and integrated digital functionality. Because consumables create recurring pull-through revenue, installed-base competition remains strategically critical.

Femtosecond Laser Cataract Systems

Femtosecond laser systems and related procedural components account for an estimated USD 0.24 billion in 2025. Adoption is concentrated in premium cataract and refractive practices rather than the overall Medicare cataract population.

The segment includes laser consoles, patient interfaces, docking systems, imaging components, service contracts, and procedure-linked consumables. Future growth depends on whether manufacturers can demonstrate sufficient workflow efficiency, refractive differentiation, and economic value to justify premium capital investment.

Ophthalmic Viscosurgical Devices and Procedure Packs

Ophthalmic viscosurgical devices, customized surgical packs, tubing, drapes, blades, cannulas, fluid-management components, and procedural consumables account for approximately USD 0.33 billion in 2025.

This is an attractive recurring-revenue category because demand scales directly with procedure volume. Health systems and ASCs increasingly seek customized packs that reduce setup steps, excess inventory, and unused components.

IOL Delivery Systems and Ophthalmic Surgical Instruments

IOL injectors, cartridges, insertion systems, forceps, capsulorhexis instruments, knives, manipulators, hooks, rings, irrigation and aspiration tools, and specialty devices account for an estimated USD 0.16 billion in 2025.

Preloaded IOL delivery is gaining importance because it can simplify lens preparation, reduce handling steps, improve consistency, and support high-throughput surgical workflow. Specialty instruments also remain essential for complex cataracts involving small pupils, weak zonules, dense lenses, or challenging anatomy.

 

By Surgery Type

Standard Phacoemulsification Cataract Surgery

Standard small-incision phacoemulsification remains the dominant U.S. cataract procedure and accounts for the clear majority of surgical volume. Its position is supported by mature clinical pathways, short operating times, predictable outcomes, and compatibility with ambulatory settings.

The associated device opportunity includes monofocal and enhanced monofocal IOLs, phaco cassettes, tubing, tips, OVDs, disposable packs, injectors, surgical knives, and other procedure-specific consumables.

Laser-Assisted Cataract Surgery

Laser-assisted cataract surgery represents a smaller but premium segment. Femtosecond systems may be used for capsulotomy, lens fragmentation, and selected corneal incisions. Adoption is concentrated in refractive cataract centers capable of supporting the additional capital, workflow, and patient-education requirements.

The technology is unlikely to replace conventional phaco on a unit-volume basis during the forecast period, but it remains commercially relevant because of its association with premium surgical pathways.

Premium Refractive Cataract Surgery

Premium refractive cataract surgery is the most important value-growth segment. It includes procedures involving toric, multifocal, trifocal, EDOF, adjustable, or other advanced IOLs together with advanced diagnostic and refractive-planning technologies.

Although premium procedures represent a minority of total U.S. cataract volume, their higher device revenue per case means their contribution to market growth is disproportionately large.

Complex Cataract Surgery

Complex cataract surgery includes cases involving dense cataracts, small pupils, zonular weakness, prior ocular surgery, trauma, unusual anatomy, or other circumstances requiring additional instrumentation. These procedures may require pupil expansion devices, capsular tension rings, specialized hooks, vitrectomy support, advanced viscoelastic products, or specialized IOL strategies.

The complex segment is particularly relevant to academic centers, tertiary ophthalmology practices, and populations with advanced disease or delayed access to care.

Combined Cataract and Glaucoma Procedures

Cataract extraction is increasingly combined with selected minimally invasive glaucoma procedures in appropriately diagnosed patients. The combination can create operational efficiencies by addressing lens opacity and intraocular-pressure management during the same surgical episode.

Although glaucoma implants are not counted as core cataract-device revenue in the market sizing presented here, combined procedures materially influence cataract operating-room workflow, equipment selection, surgeon training, and procedural economics.

 

By Technology

Conventional Ultrasound Phacoemulsification

Ultrasound phaco remains the core technology used in U.S. cataract extraction. The large installed base, surgeon familiarity, strong clinical evidence, and highly efficient procedure times make displacement unlikely.

Competitive differentiation increasingly comes from how energy is controlled and delivered rather than from ultrasound use itself.

Active-Fluidics and Intelligent Phaco Platforms

Advanced phaco platforms represent a faster-growing technology layer. Automated pressure sensing, responsive irrigation, advanced vacuum control, improved surge management, and software-driven optimization are designed to maintain chamber stability while increasing surgical efficiency.

High-volume facilities are particularly sensitive to improvements that reduce procedure variability and support efficient turnover.

Femtosecond Laser Technology

Femtosecond technology automates selected steps of cataract surgery. Its strongest commercial position is within premium refractive cataract programs, where precision and patient differentiation may support the economics of capital investment.

Future growth will depend on tighter integration with phaco systems, planning software, diagnostics, and procedural workflow.

Image-Guided Biometry and Surgical Navigation

Biometry, corneal measurement, digital toric planning, intraoperative guidance, and connected surgical planning are becoming central to premium cataract outcomes.

As patients increasingly expect reduced dependence on glasses, small residual refractive errors become commercially important. This is strengthening demand for technologies that improve IOL power prediction and toric-axis accuracy.

Advanced IOL Optical Technology

Advanced optics represent the highest-growth technology segment by value. Enhanced monofocal, toric, multifocal, trifocal, EDOF, and postoperative-adjustable technologies allow manufacturers to increase revenue per procedure without requiring equivalent increases in surgical volume.

Competition through 2035 will center on achieving wider functional vision while minimizing halos, glare, contrast loss, refractive surprises, and adaptation difficulties.

 

By End User

Ambulatory Surgery Centers

Ambulatory surgery centers represent the largest end-user category in the U.S. cataract surgery devices market. Cataract surgery fits ASC economics exceptionally well because of high procedure standardization, short cases, limited postoperative recovery requirements, and predictable supply consumption.

ASC purchasing committees prioritize per-case consumable cost, surgeon preference, room turnover, equipment uptime, service response, pack standardization, and the ability to negotiate across large annual procedure volumes.

Hospitals and Hospital Outpatient Departments

Hospitals retain an important role, especially for medically complex patients, combined procedures, academic ophthalmology programs, and cases requiring broader anesthesia or clinical support.

Hospital procurement tends to involve more structured capital budgeting and value-analysis processes than independent ophthalmology ASCs. Equipment vendors must therefore demonstrate clinical utility, service reliability, interoperability, and lifecycle economics.

Ophthalmology Clinics and Physician-Owned Surgical Facilities

Large ophthalmology groups are strategically important because they may control the entire patient pathway from diagnosis and biometry through lens counseling, surgery, and postoperative care.

Integrated ownership can increase incentives to invest in premium IOL education, refractive diagnostics, efficient surgical technology, and standardized procedural platforms.

Academic Eye Institutes

Academic and tertiary eye centers account for a smaller share of routine cataract volume but exert disproportionate influence on technology adoption. They manage complex cases, participate in clinical trials, train ophthalmologists, generate peer-reviewed evidence, and evaluate emerging IOL and surgical technologies.

Integrated Multispecialty Networks

Large physician networks and health systems are becoming increasingly important as ophthalmology consolidates. Centralized contracting can shift market share quickly if a network standardizes surgical equipment, IOLs, procedure packs, or diagnostics across multiple facilities.

Manufacturers with broad cataract portfolios and enterprise contracting capabilities are well positioned in this environment.

 

Regional Insights: Where the Market is Growing Fastest

The U.S. Cataract Surgery Devices Market is geographically segmented into the South, West, Northeast, and Midwest. Regional demand is determined primarily by the size and age of the population, Medicare beneficiary density, ophthalmologist availability, ASC concentration, private-pay premium adoption, health-system infrastructure, retirement migration, and access to refractive cataract specialists.

The South represents the largest regional market in 2025, while the West is expected to deliver the fastest percentage growth through 2035. The Northeast remains a high-value premium and academic market, and the Midwest provides a large, stable procedure base with significant installed cataract equipment.

South

The South represents an estimated USD 1.03 billion cataract surgery devices market in 2025 and is projected to reach approximately USD 2.22 billion by 2035, representing an implied CAGR of nearly 8.0%.

Its leadership reflects a combination of population size, aging demographics, rapid migration into retirement-oriented states, large Medicare populations, high ASC penetration, and expansion of physician-owned ophthalmology networks.

Florida is one of the most commercially important cataract markets in the United States. Its large elderly population, retirement communities, substantial Medicare base, and dense ophthalmology infrastructure generate exceptionally strong cataract surgical demand. Premium IOL adoption is also supported by comparatively affluent retirement populations in South Florida, Naples, Tampa, Sarasota, Orlando, and other metropolitan markets.

Texas provides the other major Southern demand center. Houston, Dallas-Fort Worth, Austin, and San Antonio support large ophthalmology networks, hospital systems, surgery centers, and private-pay refractive programs. Population growth adds an additional structural advantage and supports long-term cataract procedure expansion.

North Carolina, Georgia, Tennessee, and Virginia are attractive growth markets because of expanding metropolitan populations, consolidation of specialty practices, ASC development, and well-established academic ophthalmology programs.

South Carolina is benefiting from retirement migration along coastal communities, while Arizona-like demographic patterns are emerging in selected southeastern retirement destinations, increasing demand for high-throughput cataract infrastructure.

Maryland and Virginia contain sophisticated hospital and academic markets with strong use of premium diagnostics and complex ophthalmic surgery. Kentucky, Alabama, Mississippi, Louisiana, Arkansas, Oklahoma, and West Virginia have meaningful cataract need but show greater variation in specialist availability, rural access, and premium self-pay penetration.

These states create two distinct commercial opportunities. Large metropolitan centers support premium lenses and advanced cataract platforms, while rural and lower-income markets favor cost-efficient phaco systems, conventional IOLs, dependable procedure packs, and scalable surgical delivery models.

The South should retain the largest regional share through 2035 because demographic growth and migration continuously replenish the cataract-eligible population.

West

The West accounted for an estimated USD 0.69 billion in 2025 and is forecast to reach approximately USD 1.61 billion by 2035, producing an implied CAGR of approximately 8.8%, the fastest among the four regions.

California is the dominant Western state market because of its large population, extensive ophthalmology infrastructure, affluent private-pay patient base, academic centers, ASC networks, and high adoption of advanced refractive technologies.

Southern California is especially important for premium cataract surgery. Los Angeles, Orange County, San Diego, and surrounding markets combine high surgeon density with strong consumer familiarity with refractive procedures. Northern California provides sophisticated academic and integrated health-system demand around the Bay Area and Sacramento.

Arizona represents one of the most attractive demographic cataract markets nationally. Large retirement communities and rapid population growth create a favorable environment for cataract surgery, premium IOLs, toric lenses, and high-throughput ambulatory facilities.

Nevada shows similar characteristics, particularly around Las Vegas, where rapid population growth and retirement migration support continued ophthalmology expansion.

Washington and Oregon have mature integrated health systems and strong adoption of data-enabled care. Buyers in these states tend to place substantial emphasis on evidence, workflow efficiency, and system integration.

Colorado and Utah are faster-growing markets supported by expanding metropolitan populations and well-developed specialty-care networks. Both states are attractive for premium cataract technologies among commercially insured and higher-income populations.

New Mexico, Idaho, Montana, Wyoming, Alaska, and Hawaii are smaller markets but require distinct access strategies because of population dispersion and specialist distribution. Manufacturers with reliable service models and efficient distributor networks can create meaningful competitive advantages in these geographies.

The West should gain market share through 2035 because it combines demographic expansion, premium technology adoption, entrepreneurial ophthalmology practices, and rapid diffusion of digital surgical technologies.

Northeast

The Northeast represented an estimated USD 0.63 billion market in 2025 and is expected to reach approximately USD 1.25 billion by 2035.

The region is more mature demographically and has slower population growth than the South or West, but its value per procedure is comparatively attractive because of sophisticated provider networks, academic medical centers, strong private insurance participation, and early adoption of premium ophthalmic technologies.

New York is the region’s largest state-level opportunity. The New York City metropolitan area supports a dense network of ophthalmologists, multispecialty groups, hospital systems, ASCs, and premium refractive centers. Upstate New York contributes additional Medicare-driven cataract demand.

Pennsylvania combines large elderly populations with extensive community ophthalmology and academic infrastructure across Philadelphia, Pittsburgh, and regional markets.

New Jersey benefits from high population density and proximity to both New York and Philadelphia, creating strong demand for premium cataract and refractive services.

Massachusetts is commercially influential beyond its population size because Boston’s academic ophthalmology institutions and technology ecosystem contribute to clinical evaluation and adoption of emerging surgical platforms.

Connecticut, Rhode Island, New Hampshire, Maine, Vermont, and Delaware are smaller state markets but include comparatively high proportions of older residents in several locations, supporting stable cataract procedural demand.

The Northeast is unlikely to lead national unit-volume growth, but it remains a strategically important launch market for premium IOLs, image-guided systems, clinical studies, and complex cataract technologies.

Midwest

The Midwest accounted for approximately USD 0.51 billion in 2025 and is projected to approach USD 0.96 billion by 2035.

The region provides a large and dependable cataract surgery base built around mature community ophthalmology practices, integrated health systems, academic eye institutes, and extensive Medicare populations.

Illinois is the largest Midwestern state market, led by the Chicago metropolitan area and its combination of academic centers, independent ophthalmology practices, and multisite ASCs.

Ohio has a substantial older population and strong hospital and ambulatory ophthalmic infrastructure across Cleveland, Columbus, Cincinnati, and surrounding communities.

Michigan is another major procedure market with established ophthalmology groups and a meaningful Medicare patient base.

Minnesota is strategically important because of its broader medical-device ecosystem, integrated provider networks, and sophisticated surgical purchasing behavior.

Wisconsin, Indiana, Missouri, Iowa, and Kansas generate stable cataract demand, with purchasing decisions often emphasizing equipment reliability, long-term service support, clinical efficiency, and cost per case.

Nebraska, North Dakota, and South Dakota are smaller device markets but have significant rural populations, making referral-center efficiency and geographic access particularly important.

The Midwest is expected to grow more slowly than the South or West but remains attractive because manufacturers can build durable share through long-term surgeon relationships, enterprise health-system contracts, dependable field service, and competitive consumable economics.

 

Key Market Players

The U.S. Cataract Surgery Devices Competitive Landscape is moderately consolidated across premium IOLs and surgical capital equipment but considerably more fragmented across instruments, lasers, disposables, injectors, and specialized cataract technologies.

Competition is increasingly ecosystem-based. Companies capable of linking biometry, surgical planning, visualization, phacoemulsification, IOLs, injectors, procedure packs, service, and postoperative analytics can exert greater influence over purchasing decisions than companies competing in one isolated product category.

Some of the key participants in the U.S. cataract surgery devices ecosystem include:

Alcon
Johnson & Johnson Surgical Vision
Bausch + Lomb
Carl Zeiss Meditec
HOYA Surgical Optics
Rayner
RxSight
LENSAR
BVI Medical
Glaukos Corporation
Lenstec
HumanOptics
OPHTEC
Oertli Instrumente
NIDEK
Ziemer Ophthalmic Systems
Topcon Healthcare
Haag-Streit
Leica Microsystems
Microsurgical Technology
ASICO
Katena Products
Diamatrix
Rhein Medical

Alcon holds one of the most comprehensive cataract portfolios in the U.S. market, spanning phaco systems, IOLs, injectors, OVDs, procedure packs, surgical consumables, and digital workflow technologies. The transition toward the UNITY platform creates a significant installed-base replacement opportunity.

Johnson & Johnson Surgical Vision competes strongly through the TECNIS IOL portfolio, cataract surgical equipment, premium presbyopia-correcting technologies, delivery systems, and connected surgical workflow. Expansion of the TECNIS Odyssey platform and newer EDOF technologies strengthens its premium-IOL position.

Bausch + Lomb combines cataract equipment, IOLs, OVDs, instruments, and pharmaceuticals. Its enVista platform is strategically relevant as the company expands its premium lens portfolio.

Carl Zeiss Meditec competes through surgical visualization, optical biometry, digital planning, microscopes, phaco technology, and workflow integration, giving it a particularly strong position around precision cataract surgery.

HOYA, Rayner, RxSight, and BVI provide differentiated competitive pressure in advanced lens technologies. RxSight is especially significant within the premium segment because postoperative adjustability provides a fundamentally different pathway to refractive optimization.

LENSAR and Ziemer contribute to femtosecond laser competition, while numerous specialist companies compete in surgical instruments, disposable products, pupil expansion, capsular support, visualization, and procedural accessories.

Market share through 2035 will increasingly depend on clinical evidence, premium-IOL performance, surgeon training, installed equipment base, procedural economics, supply reliability, service response, contracting flexibility, digital connectivity, and the ability to demonstrate consistently strong refractive outcomes.

 

Recent Developments

Recent developments in the U.S. Cataract Surgery Devices Market demonstrate that competition is intensifying simultaneously in surgical equipment and premium intraocular lenses.

A major capital-equipment development occurred with U.S. regulatory clearance and subsequent commercialization of next-generation cataract surgical platforms designed to replace older installed systems. New equipment introduced into the U.S. market emphasizes more efficient phacoemulsification, reduced energy delivery, simplified setup and teardown, improved fluidics, remote servicing, and better OR utilization. This is likely to accelerate replacement decisions among large cataract ASCs over the next several years.

Premium-IOL competition also intensified substantially. New full-range lenses expanded commercial availability in the U.S. during 2024, targeting patients seeking reduced spectacle dependence across distance, intermediate, and near vision.

Another major development was the U.S. approval of Bausch + Lomb’s enVista Envy and enVista Envy Toric intraocular lenses in 2024, adding another major competitor to the presbyopia-correcting segment.

Premium-IOL adoption continued to gain commercial scale during 2025. One recently launched full-range IOL surpassed 100,000 U.S. implanted eyes after its 2024 launch, illustrating how rapidly a clinically differentiated premium lens can gain traction when supported by surgeon education and patient demand.

The innovation cycle accelerated further in 2026 with U.S. approval and rollout of another advanced EDOF IOL designed to provide extended range while maintaining contrast characteristics comparable with an aspheric monofocal lens. These launches are creating a more segmented premium market in which patients and surgeons can choose among trifocal, full-range, EDOF, enhanced-monofocal, toric, and postoperative-adjustable strategies.

At the same time, manufacturers are investing in preloaded delivery systems, automated lens preparation, digital surgical planning, biometry integration, toric alignment tools, and connected equipment ecosystems. This indicates that competitive advantage is moving beyond the optic itself toward the reproducibility of the entire refractive cataract workflow.

Consolidation among U.S. ophthalmology practices is another important market development. Larger physician organizations can standardize lens formularies, negotiate procedural packs across multiple ASCs, centralize capital purchases, and create formal premium-IOL counseling programs. This increases both the opportunity and the risk for manufacturers: winning an enterprise contract can deliver substantial volume, while losing standardization can affect multiple facilities simultaneously.

 

Conclusion

The U.S. Cataract Surgery Devices Market Size & Share is positioned for sustained expansion from approximately USD 2.86 billion in 2025 to USD 6.04 billion by 2035, representing a CAGR of approximately 7.76% during 2026–2035.

The market is supported by unusually strong structural fundamentals. Approximately 4 million cataract surgeries are performed each year in the United States, while more than 61 million Americans are already aged 65 or older. These demographic and procedural foundations provide a large recurring market for IOLs, surgical equipment, OVDs, disposables, injectors, procedure packs, lasers, and instrumentation.

However, procedure-volume expansion alone will not define market performance. The more important value driver will be premiumization. The transition from conventional monofocal cataract correction toward toric, full-range, EDOF, enhanced-monofocal, adjustable, and other advanced lens technologies is increasing the economic value of each surgical episode.

Capital-equipment competition will also enter an important replacement phase. New-generation phaco platforms that improve fluidics, reduce energy, simplify staff workflow, shorten turnover, and support connected service models will increasingly replace older installed systems. Because each console can influence years of proprietary disposable purchasing, capital placement will remain one of the most strategically important competitive battlegrounds.

Ambulatory surgery centers will remain the most influential end-user environment. High-volume cataract ASCs increasingly evaluate technology through total procedure economics: case time, staff requirements, disposable spend, room utilization, equipment reliability, lens inventory, reimbursement, premium conversion, postoperative outcomes, and surgeon satisfaction.

Regionally, the South will remain the largest market, driven particularly by Florida, Texas, North Carolina, Georgia, Virginia, and Tennessee. The West is expected to grow fastest, supported by California, Arizona, Nevada, Washington, Colorado, and Utah. The Northeast will retain strong premium and academic influence, while the Midwest will provide stable, high-volume cataract demand.

For clients evaluating this industry, the strategic issue is therefore no longer whether U.S. cataract procedure demand will expand. The critical questions are how quickly premium-IOL penetration will increase, which phaco platforms will dominate the next equipment cycle, where ASC consolidation will shift purchasing power, and which companies can translate improved clinical performance into measurable surgical and economic value.

Manufacturers positioned around advanced IOL optics, active-fluidics phacoemulsification, high-throughput ASC workflow, integrated refractive planning, preloaded delivery, postoperative adjustability, digital navigation, and recurring consumable pull-through are likely to capture a disproportionate share of U.S. cataract surgery device growth through 2035.

 

TABLE OF CONTENT

1. U.S. Cataract Surgery Devices Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Market Sizing, Procedure-Volume Mapping & Forecasting Models
1.3.6. Data Triangulation, Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Cataract Surgery Devices Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Intraocular Lens Manufacturers
1.6.2. Phacoemulsification and Cataract Surgical System Manufacturers
1.6.3. Ophthalmic Surgical Consumable and Instrument Suppliers
1.6.4. Hospitals and Hospital Outpatient Departments
1.6.5. Ambulatory Surgery Centers
1.6.6. Ophthalmology Practices and Physician-Owned Surgical Facilities
1.6.7. Integrated Ophthalmology and Multispecialty Networks
1.6.8. Group Purchasing Organizations and Distributors
1.6.9. Ophthalmologists, Cataract Surgeons and Clinical Decision-Makers
1.6.10. CMS, Commercial Payers, FDA and Other Regulatory Stakeholders

What this section provides: This section defines the U.S. cataract surgery devices market boundary, study scope, research methodology, assumptions, procedure ecosystem, and key stakeholder groups so clients can understand how market size, device demand, cataract procedure volumes, and commercial opportunities are measured and validated.

2. U.S. Cataract Surgery Devices Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. U.S. Cataract Procedure Volume Outlook
2.8. Premium IOL Penetration Outlook
2.9. ASC Cataract Surgery Adoption Snapshot
2.10. High-Growth Opportunity Areas
2.11. Key Investment and Commercial Priorities

What this section provides: This section provides executives with a concise view of U.S. cataract surgery device market size, historical performance, 2025 positioning, 2026–2035 growth expectations, procedure-volume trends, premium IOL opportunities, ASC penetration, and the most attractive commercial growth pockets.

3. U.S. Cataract Surgery Devices Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Rapid Expansion of the U.S. Population Aged 65 Years and Older
3.1.2. High and Recurring U.S. Cataract Surgery Procedure Volumes
3.1.3. Increasing Adoption of Premium and Presbyopia-Correcting IOLs
3.1.4. Growing Demand for Toric IOLs and Astigmatism Correction
3.1.5. Migration of Cataract Procedures Toward Ambulatory Surgery Centers
3.1.6. Replacement Cycle for Phacoemulsification Systems
3.1.7. Increasing Patient Expectations for Spectacle Independence
3.1.8. Expansion of Digital Biometry and Refractive Surgical Planning
3.2. Restraints and Their Impact Analysis
3.2.1. High Out-of-Pocket Cost of Premium IOL Technologies
3.2.2. Limited Reimbursement for Premium Refractive Functionality
3.2.3. Capital Cost of Advanced Phaco and Femtosecond Laser Systems
3.2.4. Visual Dysphotopsia and Patient Adaptation Concerns
3.2.5. Variability in Postoperative Refractive Outcomes
3.2.6. Competitive Pricing Pressure on Standard Monofocal IOLs
3.3. Opportunities and Their Impact Analysis
3.3.1. Extended-Depth-of-Focus IOL Adoption
3.3.2. Trifocal and Full-Range Vision IOL Expansion
3.3.3. Light-Adjustable and Postoperatively Adjustable IOLs
3.3.4. Advanced Toric Cataract Surgery
3.3.5. Premium Cataract Surgery Programs in ASCs
3.3.6. Connected Cataract Operating Rooms
3.3.7. AI-Assisted IOL Calculation and Surgical Planning
3.3.8. Preloaded IOL Delivery Systems
3.3.9. Customized Cataract Procedure Packs and Waste Reduction
3.4. Challenges and Their Impact Analysis
3.4.1. Cataract Surgeon Workforce and Geographic Access Gaps
3.4.2. ASC Cost-Containment Pressure
3.4.3. Increasing Complexity of Premium IOL Patient Selection
3.4.4. Product Recall, Sterility and Quality-Control Risks
3.4.5. Supply Chain Dependence for Precision Ophthalmic Components
3.5. Patent & Innovation Analysis, 2021–2025
3.6. U.S. Cataract Procedure Volume Trend Analysis
3.7. Cataract Surgical Workflow Economics Analysis
3.8. Premium IOL Patient Conversion Economics
3.9. Cataract Surgery ASC Throughput Analysis
3.10. Hospital and ASC Capital Procurement Behavior Analysis
3.11. Surgeon Preference and Vendor Standardization Analysis

What this section provides: This section analyzes the demographic, procedural, technological, reimbursement, patient-choice, and operational forces shaping the U.S. cataract surgery devices market and identifies the factors most likely to accelerate or constrain demand through 2035.

4. U.S. Cataract Surgery Devices Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Cataract Surgery Providers
4.2.3. Bargaining Power of Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry
4.3. Pricing Trend Analysis, 2025–2035
4.3.1. Standard Monofocal IOL Pricing
4.3.2. Toric IOL Pricing
4.3.3. Presbyopia-Correcting and EDOF IOL Pricing
4.3.4. Phacoemulsification System Pricing
4.3.5. Femtosecond Laser System Pricing
4.3.6. Cataract Surgical Consumables Pricing
4.4. Value Chain & Supply Chain Analysis
4.5. Cataract Surgery Procedure Economics
4.6. ASC Versus Hospital Outpatient Cataract Economics
4.7. Impact of Ophthalmology Practice Consolidation
4.8. Digitalization of Cataract Surgical Workflow
4.9. Application & Innovation Landscape
4.10. FDA Regulatory Framework Analysis
4.11. CMS Cataract Surgery Reimbursement and Coverage Landscape
4.12. Premium IOL Patient-Pay Regulatory Framework
4.13. Import/Export Restrictions & Tariff Impact
4.14. Raw Material and Precision Optical Component Supply Analysis
4.15. Government Eye Health and Healthy Aging Initiatives
4.16. Impact of Escalating Geopolitical and Supply Chain Tensions
4.17. ASC and Hospital Value Analysis Decision Framework
4.18. Cataract Equipment Capital Replacement Cycle Analysis
4.19. Sustainability, Surgical Waste and Procedure-Pack Optimization

What this section provides: This section provides a comprehensive view of regulation, reimbursement, premium patient-pay economics, cataract procedure profitability, capital equipment purchasing, supply-chain exposure, competitive forces, pricing, technology adoption, and the broader external environment affecting U.S. market performance.

5. U.S. Cataract Surgery Devices Market – By Product Type

5.1. Overview
5.1.1. Segment Share Analysis, By Product Type, 2025 & 2035 (%)
5.1.2. Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
5.2. Intraocular Lenses
5.2.1. Monofocal IOLs
5.2.1.1. Conventional Monofocal IOLs
5.2.1.2. Enhanced Monofocal IOLs
5.2.2. Toric IOLs
5.2.2.1. Monofocal Toric IOLs
5.2.2.2. Presbyopia-Correcting Toric IOLs
5.2.3. Multifocal and Trifocal IOLs
5.2.3.1. Multifocal IOLs
5.2.3.2. Trifocal/Full-Range IOLs
5.2.4. Extended-Depth-of-Focus IOLs
5.2.5. Adjustable and Customizable IOLs
5.2.5.1. Light-Adjustable IOLs
5.2.5.2. Other Postoperatively Adjustable IOL Technologies
5.3. Phacoemulsification Systems and Accessories
5.3.1. Phacoemulsification Consoles
5.3.2. Phaco Handpieces
5.3.3. Ultrasound Tips and Sleeves
5.3.4. Irrigation and Aspiration Systems
5.3.5. Fluidics Cassettes and Tubing Sets
5.3.6. Disposable Phaco Accessories
5.4. Femtosecond Laser Cataract Surgery Systems
5.4.1. Femtosecond Laser Consoles
5.4.2. Patient Interface and Docking Systems
5.4.3. Imaging and Guidance Components
5.4.4. Procedure-Specific Laser Consumables
5.5. Ophthalmic Viscosurgical Devices and Procedure Packs
5.5.1. Cohesive OVDs
5.5.2. Dispersive OVDs
5.5.3. Combination OVD Systems
5.5.4. Cataract Procedure Packs
5.5.5. Surgical Drapes, Cannulas and Fluid Management Consumables
5.6. IOL Delivery Systems and Cataract Surgical Instruments
5.6.1. Preloaded IOL Delivery Systems
5.6.2. IOL Injectors and Cartridges
5.6.3. Ophthalmic Knives and Blades
5.6.4. Capsulorhexis Forceps and Manipulators
5.6.5. Pupil Expansion Devices
5.6.6. Capsular Tension Rings and Support Devices
5.6.7. Other Cataract Surgical Instruments

What this section provides: This section identifies the device categories contributing the largest revenue pools and fastest growth within U.S. cataract surgery, with detailed visibility into conventional lenses, premium IOLs, phaco platforms, femtosecond systems, OVDs, procedure packs, delivery systems, and surgical instrumentation.

6. U.S. Cataract Surgery Devices Market – By Surgery Type

6.1. Overview
6.1.1. Segment Share Analysis, By Surgery Type, 2025 & 2035 (%)
6.1.2. Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
6.2. Standard Phacoemulsification Cataract Surgery
6.2.1. Routine Age-Related Cataract Surgery
6.2.2. Small-Incision Phacoemulsification
6.2.3. Conventional Monofocal IOL Procedures
6.2.4. Enhanced Monofocal IOL Procedures
6.3. Laser-Assisted Cataract Surgery
6.3.1. Femtosecond Laser Capsulotomy
6.3.2. Laser Lens Fragmentation
6.3.3. Laser Corneal Incision Procedures
6.3.4. Laser-Assisted Astigmatism Management
6.4. Premium Refractive Cataract Surgery
6.4.1. Toric IOL Cataract Surgery
6.4.2. Multifocal/Trifocal IOL Cataract Surgery
6.4.3. EDOF IOL Cataract Surgery
6.4.4. Adjustable IOL Cataract Surgery
6.4.5. Premium Image-Guided Cataract Surgery
6.5. Complex Cataract Surgery
6.5.1. Dense and Mature Cataract Surgery
6.5.2. Small-Pupil Cataract Surgery
6.5.3. Zonular Weakness and Capsular Support Cases
6.5.4. Post-Refractive Surgery Cataract Procedures
6.5.5. Cataract Surgery in Challenging Ocular Anatomy
6.6. Combined Cataract Procedures
6.6.1. Cataract Surgery with Minimally Invasive Glaucoma Surgery
6.6.2. Cataract Surgery with Corneal Procedures
6.6.3. Cataract Surgery with Vitreoretinal Intervention
6.6.4. Other Combined Ophthalmic Procedures

What this section provides: This section evaluates device demand according to cataract procedure type, helping clients understand the relative commercial importance of routine phacoemulsification, premium refractive cataract surgery, laser-assisted surgery, complex cases, and combined ophthalmic procedures.

7. U.S. Cataract Surgery Devices Market – By Technology

7.1. Overview
7.1.1. Segment Share Analysis, By Technology, 2025 & 2035 (%)
7.1.2. Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
7.2. Conventional Ultrasound Phacoemulsification Technology
7.2.1. Longitudinal Ultrasound
7.2.2. Torsional/Oscillatory Ultrasound
7.2.3. Combined Ultrasound Modes
7.3. Active-Fluidics and Intelligent Phaco Technology
7.3.1. Active Pressure Control
7.3.2. Advanced Vacuum and Aspiration Control
7.3.3. Chamber Stability and Surge Management
7.3.4. Energy Optimization Algorithms
7.3.5. Connected and Software-Enabled Phaco Systems
7.4. Femtosecond Laser Technology
7.4.1. Image-Guided Femtosecond Platforms
7.4.2. Automated Capsulotomy Technology
7.4.3. Lens Fragmentation Technology
7.4.4. Laser Astigmatic Keratotomy
7.5. Image-Guided Biometry and Surgical Navigation
7.5.1. Optical Biometry
7.5.2. Corneal Topography and Tomography
7.5.3. Digital Toric IOL Planning
7.5.4. Intraoperative Aberrometry
7.5.5. Digital Surgical Guidance
7.5.6. AI-Assisted IOL Power Calculation
7.6. Advanced IOL Optical Technology
7.6.1. Enhanced Monofocal Optics
7.6.2. Diffractive Multifocal and Trifocal Optics
7.6.3. Extended-Depth-of-Focus Optics
7.6.4. Toric Optical Platforms
7.6.5. Non-Diffractive Presbyopia-Correcting Optics
7.6.6. Postoperatively Adjustable Lens Technology

What this section provides: This section evaluates the technology platforms redefining cataract surgery, including ultrasound phaco, active fluidics, femtosecond lasers, digital surgical guidance, AI-enabled planning, and advanced intraocular lens optics.

8. U.S. Cataract Surgery Devices Market – By End User

8.1. Overview
8.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
8.1.2. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
8.2. Ambulatory Surgery Centers
8.2.1. Independent Ophthalmology ASCs
8.2.2. Physician-Owned ASCs
8.2.3. Corporate/Multi-Site ASC Networks
8.2.4. Hospital-Affiliated ASCs
8.3. Hospitals and Hospital Outpatient Departments
8.3.1. Community Hospitals
8.3.2. Large Health Systems
8.3.3. Hospital Outpatient Ophthalmic Surgery Departments
8.4. Ophthalmology Clinics and Physician-Owned Surgical Facilities
8.4.1. Independent Ophthalmology Practices
8.4.2. Multisite Ophthalmology Groups
8.4.3. Cataract and Refractive Surgery Practices
8.5. Academic Eye Institutes and Tertiary Ophthalmology Centers
8.5.1. University Eye Hospitals
8.5.2. Academic Medical Center Ophthalmology Departments
8.5.3. Complex Cataract Referral Centers
8.6. Integrated Multispecialty and Consolidated Ophthalmology Networks
8.6.1. Private Equity-Backed Ophthalmology Networks
8.6.2. Integrated Delivery Networks
8.6.3. Multispecialty Physician Organizations

What this section provides: This section determines which U.S. care settings control cataract procedure volume, capital-equipment placement, IOL purchasing, premium-lens conversion, consumable utilization, and vendor-standardization decisions.

9. U.S. Cataract Surgery Devices Market – By Geography

9.1. Introduction
9.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
9.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
9.1.3. Regional Cataract Procedure Volume Analysis
9.1.4. Population Aged 65+ and Cataract Demand Mapping
9.1.5. Regional ASC and Ophthalmology Infrastructure Analysis
9.1.6. Premium IOL Adoption and Patient-Pay Dynamics
9.1.7. Regional Reimbursement and Procurement Dynamics
9.1.8. Cataract Surgeon Density and Access Analysis
9.2. West Region
9.2.1. Regional Overview & Trends
9.2.2. West Region Cataract Device Manufacturers and Procurement Ecosystem
9.2.3. West Region Cataract Procedure Volume Analysis
9.2.4. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
9.2.5. West Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.2.6. West Region Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.2.7. West Region Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.2.8. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.9. California
9.2.9.1. Overview
9.2.9.2. California Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.2.9.3. California Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.2.9.4. California Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.2.9.5. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.10. Washington
9.2.10.1. Overview
9.2.10.2. Washington Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.2.10.3. Washington Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.2.10.4. Washington Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.2.10.5. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.11. Arizona
9.2.11.1. Overview
9.2.11.2. Arizona Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.2.11.3. Arizona Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.2.11.4. Arizona Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.2.11.5. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.12. Colorado
9.2.12.1. Overview
9.2.12.2. Colorado Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.2.12.3. Colorado Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.2.12.4. Colorado Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.2.12.5. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.13. Oregon
9.2.13.1. Overview
9.2.13.2. Oregon Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.2.13.3. Oregon Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.2.13.4. Oregon Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.2.13.5. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.14. Utah
9.2.14.1. Overview
9.2.14.2. Utah Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.2.14.3. Utah Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.2.14.4. Utah Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.2.14.5. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.15. Nevada
9.2.15.1. Overview
9.2.15.2. Nevada Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.2.15.3. Nevada Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.2.15.4. Nevada Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.2.15.5. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.16. New Mexico
9.2.16.1. Overview
9.2.16.2. New Mexico Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.2.16.3. New Mexico Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.2.16.4. New Mexico Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.2.16.5. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.17. Idaho
9.2.17.1. Overview
9.2.17.2. Idaho Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.2.17.3. Idaho Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.2.17.4. Idaho Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.2.17.5. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.18. Montana
9.2.18.1. Overview
9.2.18.2. Montana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.2.18.3. Montana Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.2.18.4. Montana Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.2.18.5. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.19. Wyoming
9.2.19.1. Overview
9.2.19.2. Wyoming Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.2.19.3. Wyoming Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.2.19.4. Wyoming Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.2.19.5. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.20. Alaska
9.2.20.1. Overview
9.2.20.2. Alaska Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.2.20.3. Alaska Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.2.20.4. Alaska Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.2.20.5. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.21. Hawaii
9.2.21.1. Overview
9.2.21.2. Hawaii Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.2.21.3. Hawaii Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.2.21.4. Hawaii Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.2.21.5. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3. Northeast Region
9.3.1. Regional Overview & Trends
9.3.2. Northeast Region Cataract Device Manufacturers and Procurement Ecosystem
9.3.3. Northeast Region Cataract Procedure Volume Analysis
9.3.4. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
9.3.5. Northeast Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.3.6. Northeast Region Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.3.7. Northeast Region Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.3.8. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.9. New York
9.3.9.1. Overview
9.3.9.2. New York Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.3.9.3. New York Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.3.9.4. New York Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.3.9.5. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.10. Massachusetts
9.3.10.1. Overview
9.3.10.2. Massachusetts Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.3.10.3. Massachusetts Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.3.10.4. Massachusetts Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.3.10.5. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.11. New Jersey
9.3.11.1. Overview
9.3.11.2. New Jersey Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.3.11.3. New Jersey Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.3.11.4. New Jersey Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.3.11.5. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.12. Pennsylvania
9.3.12.1. Overview
9.3.12.2. Pennsylvania Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.3.12.3. Pennsylvania Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.3.12.4. Pennsylvania Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.3.12.5. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.13. Connecticut
9.3.13.1. Overview
9.3.13.2. Connecticut Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.3.13.3. Connecticut Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.3.13.4. Connecticut Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.3.13.5. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.14. Maine
9.3.14.1. Overview
9.3.14.2. Maine Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.3.14.3. Maine Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.3.14.4. Maine Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.3.14.5. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.15. Vermont
9.3.15.1. Overview
9.3.15.2. Vermont Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.3.15.3. Vermont Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.3.15.4. Vermont Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.3.15.5. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.16. New Hampshire
9.3.16.1. Overview
9.3.16.2. New Hampshire Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.3.16.3. New Hampshire Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.3.16.4. New Hampshire Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.3.16.5. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.17. Rhode Island
9.3.17.1. Overview
9.3.17.2. Rhode Island Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.3.17.3. Rhode Island Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.3.17.4. Rhode Island Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.3.17.5. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.18. Delaware
9.3.18.1. Overview
9.3.18.2. Delaware Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.3.18.3. Delaware Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.3.18.4. Delaware Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.3.18.5. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4. South Region
9.4.1. Regional Overview & Trends
9.4.2. South Region Cataract Device Manufacturers and Procurement Ecosystem
9.4.3. South Region Cataract Procedure Volume Analysis
9.4.4. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
9.4.5. South Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.4.6. South Region Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.4.7. South Region Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.4.8. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.9. Texas
9.4.9.1. Overview
9.4.9.2. Texas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.4.9.3. Texas Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.4.9.4. Texas Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.4.9.5. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.10. Florida
9.4.10.1. Overview
9.4.10.2. Florida Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.4.10.3. Florida Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.4.10.4. Florida Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.4.10.5. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.11. Georgia
9.4.11.1. Overview
9.4.11.2. Georgia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.4.11.3. Georgia Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.4.11.4. Georgia Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.4.11.5. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.12. North Carolina
9.4.12.1. Overview
9.4.12.2. North Carolina Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.4.12.3. North Carolina Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.4.12.4. North Carolina Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.4.12.5. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.13. Tennessee
9.4.13.1. Overview
9.4.13.2. Tennessee Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.4.13.3. Tennessee Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.4.13.4. Tennessee Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.4.13.5. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.14. South Carolina
9.4.14.1. Overview
9.4.14.2. South Carolina Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.4.14.3. South Carolina Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.4.14.4. South Carolina Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.4.14.5. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.15. Alabama
9.4.15.1. Overview
9.4.15.2. Alabama Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.4.15.3. Alabama Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.4.15.4. Alabama Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.4.15.5. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.16. Mississippi
9.4.16.1. Overview
9.4.16.2. Mississippi Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.4.16.3. Mississippi Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.4.16.4. Mississippi Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.4.16.5. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.17. Louisiana
9.4.17.1. Overview
9.4.17.2. Louisiana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.4.17.3. Louisiana Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.4.17.4. Louisiana Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.4.17.5. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.18. Arkansas
9.4.18.1. Overview
9.4.18.2. Arkansas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.4.18.3. Arkansas Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.4.18.4. Arkansas Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.4.18.5. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.19. Kentucky
9.4.19.1. Overview
9.4.19.2. Kentucky Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.4.19.3. Kentucky Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.4.19.4. Kentucky Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.4.19.5. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.20. Oklahoma
9.4.20.1. Overview
9.4.20.2. Oklahoma Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.4.20.3. Oklahoma Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.4.20.4. Oklahoma Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.4.20.5. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.21. Virginia
9.4.21.1. Overview
9.4.21.2. Virginia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.4.21.3. Virginia Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.4.21.4. Virginia Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.4.21.5. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.22. Maryland
9.4.22.1. Overview
9.4.22.2. Maryland Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.4.22.3. Maryland Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.4.22.4. Maryland Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.4.22.5. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.23. West Virginia
9.4.23.1. Overview
9.4.23.2. West Virginia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.4.23.3. West Virginia Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.4.23.4. West Virginia Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.4.23.5. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5. Midwest Region
9.5.1. Regional Overview & Trends
9.5.2. Midwest Region Cataract Device Manufacturers and Procurement Ecosystem
9.5.3. Midwest Region Cataract Procedure Volume Analysis
9.5.4. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
9.5.5. Midwest Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.5.6. Midwest Region Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.5.7. Midwest Region Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.5.8. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.9. Illinois
9.5.9.1. Overview
9.5.9.2. Illinois Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.5.9.3. Illinois Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.5.9.4. Illinois Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.5.9.5. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.10. Ohio
9.5.10.1. Overview
9.5.10.2. Ohio Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.5.10.3. Ohio Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.5.10.4. Ohio Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.5.10.5. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.11. Michigan
9.5.11.1. Overview
9.5.11.2. Michigan Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.5.11.3. Michigan Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.5.11.4. Michigan Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.5.11.5. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.12. Minnesota
9.5.12.1. Overview
9.5.12.2. Minnesota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.5.12.3. Minnesota Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.5.12.4. Minnesota Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.5.12.5. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.13. Indiana
9.5.13.1. Overview
9.5.13.2. Indiana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.5.13.3. Indiana Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.5.13.4. Indiana Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.5.13.5. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.14. Wisconsin
9.5.14.1. Overview
9.5.14.2. Wisconsin Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.5.14.3. Wisconsin Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.5.14.4. Wisconsin Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.5.14.5. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.15. Missouri
9.5.15.1. Overview
9.5.15.2. Missouri Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.5.15.3. Missouri Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.5.15.4. Missouri Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.5.15.5. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.16. Iowa
9.5.16.1. Overview
9.5.16.2. Iowa Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.5.16.3. Iowa Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.5.16.4. Iowa Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.5.16.5. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.17. Kansas
9.5.17.1. Overview
9.5.17.2. Kansas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.5.17.3. Kansas Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.5.17.4. Kansas Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.5.17.5. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.18. Nebraska
9.5.18.1. Overview
9.5.18.2. Nebraska Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.5.18.3. Nebraska Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.5.18.4. Nebraska Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.5.18.5. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.19. North Dakota
9.5.19.1. Overview
9.5.19.2. North Dakota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.5.19.3. North Dakota Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.5.19.4. North Dakota Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.5.19.5. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.20. South Dakota
9.5.20.1. Overview
9.5.20.2. South Dakota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.5.20.3. South Dakota Market Size and Forecast, By Surgery Type, 2021–2035 (US$ Billion)
9.5.20.4. South Dakota Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.5.20.5. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

What this section provides: This section delivers detailed four-region and 50-state analysis of U.S. cataract surgery device demand, procedure volumes, aging demographics, ASC infrastructure, premium IOL adoption, technology penetration, and state-level commercial opportunities through 2035.

10. U.S. Cataract Surgery Devices Market: Competitive Landscape & Company Profiles

10.1. Market Share Analysis, 2025
10.1.1. Overall Cataract Surgery Devices Market Share
10.1.2. Intraocular Lens Market Share
10.1.3. Premium IOL Competitive Share
10.1.4. Phacoemulsification Systems Installed-Base Share
10.1.5. Femtosecond Cataract Laser Competitive Share
10.2. Company Positioning Matrix
10.2.1. Market Leaders
10.2.2. Challengers
10.2.3. Technology Innovators
10.2.4. Specialty Cataract Device Players
10.2.5. Emerging Players
10.3. Competitive Benchmarking
10.3.1. Product Portfolio Breadth
10.3.2. Premium IOL Positioning
10.3.3. Cataract Capital Equipment Installed Base
10.3.4. Digital Workflow Capabilities
10.3.5. ASC Contracting Strength
10.3.6. Clinical Evidence and Surgeon Adoption
10.3.7. U.S. Distribution and Service Infrastructure
10.4. Company Profiles
10.4.1. Alcon Inc.
10.4.2. Johnson & Johnson Surgical Vision
10.4.3. Bausch + Lomb
10.4.4. Carl Zeiss Meditec AG
10.4.5. HOYA Surgical Optics
10.4.6. Rayner
10.4.7. RxSight, Inc.
10.4.8. LENSAR, Inc.
10.4.9. BVI Medical
10.4.10. Glaukos Corporation
10.4.11. Lenstec, Inc.
10.4.12. HumanOptics AG
10.4.13. OPHTEC
10.4.14. Oertli Instrumente AG
10.4.15. NIDEK CO., LTD.
10.4.16. Ziemer Ophthalmic Systems AG
10.4.17. Topcon Healthcare
10.4.18. Haag-Streit Group
10.4.19. Leica Microsystems
10.4.20. Microsurgical Technology
10.4.21. ASICO LLC
10.4.22. Katena Products
10.4.23. Diamatrix Ltd.
10.4.24. Rhein Medical
10.4.25. Corza Ophthalmology

Note: Each company profile will include company overview, cataract surgery device portfolio, U.S. market presence, intraocular lens positioning, capital-equipment strategy where applicable, clinical evidence, FDA/regulatory developments, partnerships, commercial strategy, product launches, and recent developments.

What this section provides: This section provides competitor benchmarking, 2025 market-share visibility, premium IOL positioning, surgical equipment installed-base intelligence, portfolio comparisons, innovation strategy, ASC commercial positioning, and detailed profiles of major companies participating in the U.S. cataract surgery devices market.

11. U.S. Cataract Surgery Devices Market: Future Market Outlook, 2026–2035

11.1. Scenario Analysis
11.1.1. Optimistic Growth Scenario
11.1.2. Realistic/Base-Case Growth Scenario
11.1.3. Pessimistic Growth Scenario
11.2. Disruptive Technologies Impact
11.2.1. Next-Generation Active-Fluidics Phaco Systems
11.2.2. AI-Assisted IOL Power Calculation
11.2.3. Full-Range and EDOF IOL Technologies
11.2.4. Postoperatively Adjustable IOLs
11.2.5. Non-Diffractive Presbyopia-Correcting Optics
11.2.6. Image-Guided Cataract Surgery
11.2.7. Connected Cataract Operating Rooms
11.2.8. Automated and Preloaded IOL Delivery
11.2.9. Advanced Femtosecond Laser Platforms
11.3. Future Cataract Procedure Volume Outlook
11.4. Premium IOL Penetration Forecast
11.5. Future ASC Share of Cataract Surgery
11.6. Cataract Surgeon Productivity and Workflow Outlook
11.7. Cataract Equipment Replacement Cycle, 2026–2035
11.8. Emerging Business Models
11.8.1. Enterprise Ophthalmology Contracts
11.8.2. IOL Portfolio Bundling
11.8.3. Capital Equipment–Consumable Contracts
11.8.4. Premium Cataract Patient Conversion Programs
11.8.5. Data-Enabled Cataract Workflow Ecosystems
11.9. Business Opportunities for Startups and Existing Players
11.10. Investment Prioritization Matrix
11.11. High-Growth Product Opportunity Matrix
11.12. State-Level Expansion Opportunity Matrix

What this section provides: This section prepares clients for the technology, procedure-volume, premiumization, ASC migration, capital-equipment replacement, and competitive changes expected to reshape the U.S. cataract surgery devices market between 2026 and 2035.

12. U.S. Cataract Surgery Devices Market: Strategic Recommendations

12.1. Recommendations for Cataract Device Manufacturers
12.1.1. IOL Portfolio Strategy
12.1.2. Premium IOL Conversion Strategy
12.1.3. Phaco Installed-Base Expansion Strategy
12.1.4. Consumable Pull-Through Strategy
12.1.5. Digital Cataract Workflow Strategy
12.2. Recommendations for Ambulatory Surgery Centers
12.2.1. Capital Equipment Procurement
12.2.2. Cataract OR Throughput Optimization
12.2.3. Procedure-Pack Standardization
12.2.4. Premium Lens Program Development
12.3. Recommendations for Hospitals and Health Systems
12.3.1. Cataract Service-Line Strategy
12.3.2. HOPD Versus ASC Capacity Planning
12.3.3. Vendor Standardization and Contracting
12.4. Recommendations for Ophthalmology Practices
12.4.1. Premium IOL Patient Selection
12.4.2. Patient Counseling and Conversion
12.4.3. Diagnostic and Surgical Workflow Integration
12.5. Recommendations for Investors and Private Equity Firms
12.5.1. Ophthalmology Consolidation Opportunities
12.5.2. Cataract ASC Investment Opportunities
12.5.3. Premium IOL and Surgical Technology Opportunities
12.6. Recommendations for Distributors and Channel Partners
12.7. Recommendations for New Entrants and Startups
12.8. Go-to-Market Strategy Considerations
12.9. Product Positioning and Portfolio Expansion Guidance
12.10. State-Level Commercial Prioritization
12.11. Surgeon Education and KOL Development Strategy
12.12. Reimbursement and Market Access Strategy

What this section provides: This section converts the market intelligence into actionable recommendations for manufacturers, ASCs, hospitals, ophthalmology practices, investors, distributors, and new entrants seeking growth, portfolio expansion, geographic prioritization, and sustainable competitive differentiation.

13. U.S. Cataract Surgery Devices Market: Disclaimer

13.1. Scope Limitation
13.2. Data Use Limitation
13.3. Market Sizing Limitation
13.4. Forecasting Limitation
13.5. Procedure Volume Estimation Limitation
13.6. State-Level Estimation Limitation
13.7. Legal Disclaimer
13.8. Third-Party Data Disclaimer

What this section provides: This section clarifies the report’s scope, market-sizing methodology limitations, state-level estimation boundaries, forecasting assumptions, third-party data considerations, legal limitations, and appropriate use of the research findings.

 

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Cataract Surgery Devices Market: Market Definition and Scope
TABLE 3: U.S. Cataract Surgery Devices Market: Research Methodology Framework
TABLE 4: U.S. Cataract Surgery Devices Market: Primary and Secondary Research Framework
TABLE 5: U.S. Cataract Surgery Devices Market: Market Sizing and Forecasting Methodology
TABLE 6: U.S. Cataract Surgery Devices Market: Key Assumptions
TABLE 7: U.S. Cataract Surgery Devices Market: Market Ecosystem Overview
TABLE 8: U.S. Cataract Surgery Devices Market: Stakeholder Analysis
TABLE 9: U.S. Cataract Surgery Devices Market: Executive Summary Snapshot, 2025
TABLE 10: U.S. Cataract Surgery Devices Market: Analyst Viewpoint Summary
TABLE 11: U.S. Cataract Surgery Devices Market: Market Attractiveness Index
TABLE 12: U.S. Cataract Surgery Devices Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 13: U.S. Cataract Surgery Devices Market: Base Year Market Positioning, 2025
TABLE 14: U.S. Cataract Surgery Devices Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 15: U.S. Cataract Surgery Devices Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 16: U.S. Cataract Surgery Devices Market: U.S. Cataract Procedure Volume Analysis
TABLE 17: U.S. Cataract Surgery Devices Market: Premium IOL Penetration Snapshot
TABLE 18: U.S. Cataract Surgery Devices Market: ASC Cataract Surgery Adoption Snapshot
TABLE 19: U.S. Cataract Surgery Devices Market: High-Growth Opportunity Areas
TABLE 20: U.S. Cataract Surgery Devices Market: Drivers; Impact Analysis
TABLE 21: U.S. Cataract Surgery Devices Market: Restraints; Impact Analysis
TABLE 22: U.S. Cataract Surgery Devices Market: Opportunities; Impact Analysis
TABLE 23: U.S. Cataract Surgery Devices Market: Challenges; Impact Analysis
TABLE 24: U.S. Cataract Surgery Devices Market: Patent & Innovation Analysis, 2021–2025
TABLE 25: U.S. Cataract Surgery Devices Market: Cataract Procedure Volume Trend Analysis
TABLE 26: U.S. Cataract Surgery Devices Market: Premium IOL Patient Conversion Economics
TABLE 27: U.S. Cataract Surgery Devices Market: Cataract Surgical Workflow Economics Matrix
TABLE 28: U.S. Cataract Surgery Devices Market: ASC Throughput Economics Matrix
TABLE 29: U.S. Cataract Surgery Devices Market: Capital Procurement Behavior Matrix
TABLE 30: U.S. Cataract Surgery Devices Market: Surgeon Preference and Vendor Standardization Analysis
TABLE 31: U.S. Cataract Surgery Devices Market: PESTEL Analysis
TABLE 32: U.S. Cataract Surgery Devices Market: Porter’s Five Forces Analysis
TABLE 33: U.S. Cataract Surgery Devices Market: Pricing Trend Analysis, 2025–2035
TABLE 34: U.S. Cataract Surgery Devices Market: IOL Pricing Trend Analysis, 2025–2035
TABLE 35: U.S. Cataract Surgery Devices Market: Phaco and Femtosecond Capital Equipment Pricing Analysis
TABLE 36: U.S. Cataract Surgery Devices Market: Value Chain Analysis
TABLE 37: U.S. Cataract Surgery Devices Market: Supply Chain Analysis
TABLE 38: U.S. Cataract Surgery Devices Market: Cataract Procedure Economics
TABLE 39: U.S. Cataract Surgery Devices Market: ASC Versus Hospital Outpatient Economics
TABLE 40: U.S. Cataract Surgery Devices Market: Ophthalmology Practice Consolidation Impact
TABLE 41: U.S. Cataract Surgery Devices Market: Digital Cataract Workflow Landscape
TABLE 42: U.S. Cataract Surgery Devices Market: FDA Regulatory Framework Analysis
TABLE 43: U.S. Cataract Surgery Devices Market: CMS Reimbursement and Coverage Landscape
TABLE 44: U.S. Cataract Surgery Devices Market: Premium IOL Patient-Pay Framework
TABLE 45: U.S. Cataract Surgery Devices Market: Import/Export Restrictions & Tariff Impact
TABLE 46: U.S. Cataract Surgery Devices Market: Precision Optical Component Supply Analysis
TABLE 47: U.S. Cataract Surgery Devices Market: Cataract Equipment Replacement Cycle Analysis
TABLE 48: U.S. Cataract Surgery Devices Market: Surgical Waste and Procedure-Pack Optimization
TABLE 49: U.S. Cataract Surgery Devices Market: Product Type Snapshot, 2025
TABLE 50: Segment Dashboard; Definition and Scope, by Product Type
TABLE 51: U.S. Cataract Surgery Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 52: U.S. Cataract Surgery Devices Market: Product Type Share Analysis, 2025 & 2035 (%)
TABLE 53: U.S. Cataract Surgery Devices Market: Intraocular Lenses Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 54: U.S. Cataract Surgery Devices Market: Monofocal IOL Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 55: U.S. Cataract Surgery Devices Market: Toric IOL Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 56: U.S. Cataract Surgery Devices Market: Multifocal and Trifocal IOL Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 57: U.S. Cataract Surgery Devices Market: EDOF IOL Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 58: U.S. Cataract Surgery Devices Market: Adjustable IOL Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 59: U.S. Cataract Surgery Devices Market: Phacoemulsification Systems and Accessories Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 60: U.S. Cataract Surgery Devices Market: Femtosecond Laser Cataract Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 61: U.S. Cataract Surgery Devices Market: OVDs and Procedure Packs Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 62: U.S. Cataract Surgery Devices Market: IOL Delivery Systems and Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 63: U.S. Cataract Surgery Devices Market: Surgery Type Snapshot, 2025
TABLE 64: Segment Dashboard; Definition and Scope, by Surgery Type
TABLE 65: U.S. Cataract Surgery Devices Market, by Surgery Type, 2021–2035 (US$ Billion)
TABLE 66: U.S. Cataract Surgery Devices Market: Surgery Type Share Analysis, 2025 & 2035 (%)
TABLE 67: Standard Phacoemulsification Cataract Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 68: Laser-Assisted Cataract Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 69: Premium Refractive Cataract Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 70: Complex Cataract Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 71: Combined Cataract Procedures Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 72: U.S. Cataract Surgery Devices Market: Technology Snapshot, 2025
TABLE 73: Segment Dashboard; Definition and Scope, by Technology
TABLE 74: U.S. Cataract Surgery Devices Market, by Technology, 2021–2035 (US$ Billion)
TABLE 75: U.S. Cataract Surgery Devices Market: Technology Share Analysis, 2025 & 2035 (%)
TABLE 76: Conventional Ultrasound Phacoemulsification Technology Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 77: Active-Fluidics and Intelligent Phaco Technology Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 78: Femtosecond Laser Technology Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 79: Image-Guided Biometry and Surgical Navigation Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 80: Advanced IOL Optical Technology Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 81: U.S. Cataract Surgery Devices Market: End User Snapshot, 2025
TABLE 82: Segment Dashboard; Definition and Scope, by End User
TABLE 83: U.S. Cataract Surgery Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 84: U.S. Cataract Surgery Devices Market: End User Share Analysis, 2025 & 2035 (%)
TABLE 85: Ambulatory Surgery Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 86: Hospitals and Hospital Outpatient Departments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 87: Ophthalmology Clinics and Physician-Owned Surgical Facilities Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 88: Academic Eye Institutes and Tertiary Ophthalmology Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 89: Integrated Multispecialty and Consolidated Ophthalmology Networks Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 90: U.S. Cataract Surgery Devices Market: Regional Snapshot, 2025
TABLE 91: Segment Dashboard; Definition and Scope, by Geography
TABLE 92: U.S. Cataract Surgery Devices Market, by Region, 2021–2035 (US$ Billion)
TABLE 93: U.S. Cataract Surgery Devices Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 94: U.S. Cataract Surgery Devices Market: Regional Cataract Procedure Volume Analysis
TABLE 95: U.S. Cataract Surgery Devices Market: Regional Population Aged 65+ Demand Mapping
TABLE 96: U.S. Cataract Surgery Devices Market: Regional ASC and Ophthalmology Infrastructure Analysis
TABLE 97: U.S. Cataract Surgery Devices Market: Regional Premium IOL Adoption Analysis
TABLE 98: West Region U.S. Cataract Surgery Devices Market: Regional Overview and Trends
TABLE 99: West Region U.S. Cataract Surgery Devices Market: Manufacturers and Procurement Ecosystem
TABLE 100: West Region U.S. Cataract Surgery Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 101: West Region U.S. Cataract Surgery Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 102: West Region U.S. Cataract Surgery Devices Market, by Surgery Type, 2021–2035 (US$ Billion)
TABLE 103: West Region U.S. Cataract Surgery Devices Market, by Technology, 2021–2035 (US$ Billion)
TABLE 104: West Region U.S. Cataract Surgery Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 105: California Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 106: Washington Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 107: Arizona Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 108: Colorado Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 109: Oregon Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 110: Utah Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 111: Nevada Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 112: New Mexico Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 113: Idaho Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 114: Montana Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 115: Wyoming Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 116: Alaska Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 117: Hawaii Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 118: Northeast Region U.S. Cataract Surgery Devices Market: Regional Overview and Trends
TABLE 119: Northeast Region U.S. Cataract Surgery Devices Market: Manufacturers and Procurement Ecosystem
TABLE 120: Northeast Region U.S. Cataract Surgery Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 121: Northeast Region U.S. Cataract Surgery Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 122: Northeast Region U.S. Cataract Surgery Devices Market, by Surgery Type, 2021–2035 (US$ Billion)
TABLE 123: Northeast Region U.S. Cataract Surgery Devices Market, by Technology, 2021–2035 (US$ Billion)
TABLE 124: Northeast Region U.S. Cataract Surgery Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 125: New York Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 126: Massachusetts Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 127: New Jersey Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 128: Pennsylvania Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 129: Connecticut Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 130: Maine Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 131: Vermont Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 132: New Hampshire Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 133: Rhode Island Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 134: Delaware Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 135: South Region U.S. Cataract Surgery Devices Market: Regional Overview and Trends
TABLE 136: South Region U.S. Cataract Surgery Devices Market: Manufacturers and Procurement Ecosystem
TABLE 137: South Region U.S. Cataract Surgery Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 138: South Region U.S. Cataract Surgery Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 139: South Region U.S. Cataract Surgery Devices Market, by Surgery Type, 2021–2035 (US$ Billion)
TABLE 140: South Region U.S. Cataract Surgery Devices Market, by Technology, 2021–2035 (US$ Billion)
TABLE 141: South Region U.S. Cataract Surgery Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 142: Texas Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 143: Florida Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 144: Georgia Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 145: North Carolina Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 146: Tennessee Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 147: South Carolina Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 148: Alabama Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 149: Mississippi Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 150: Louisiana Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 151: Arkansas Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 152: Kentucky Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 153: Oklahoma Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 154: Virginia Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 155: Maryland Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 156: West Virginia Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 157: Midwest Region U.S. Cataract Surgery Devices Market: Regional Overview and Trends
TABLE 158: Midwest Region U.S. Cataract Surgery Devices Market: Manufacturers and Procurement Ecosystem
TABLE 159: Midwest Region U.S. Cataract Surgery Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 160: Midwest Region U.S. Cataract Surgery Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 161: Midwest Region U.S. Cataract Surgery Devices Market, by Surgery Type, 2021–2035 (US$ Billion)
TABLE 162: Midwest Region U.S. Cataract Surgery Devices Market, by Technology, 2021–2035 (US$ Billion)
TABLE 163: Midwest Region U.S. Cataract Surgery Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 164: Illinois Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 165: Ohio Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 166: Michigan Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 167: Minnesota Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 168: Indiana Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 169: Wisconsin Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 170: Missouri Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 171: Iowa Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 172: Kansas Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 173: Nebraska Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 174: North Dakota Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 175: South Dakota Cataract Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 176: U.S. Cataract Surgery Devices Market: Competitive Landscape Snapshot, 2025
TABLE 177: U.S. Cataract Surgery Devices Market: Key Company Market Share Analysis, 2025
TABLE 178: U.S. Cataract Surgery Devices Market: Company Positioning Matrix
TABLE 179: U.S. Cataract Surgery Devices Market: Product Portfolio Benchmarking of Key Players
TABLE 180: U.S. Cataract Surgery Devices Market: Premium IOL Competitive Benchmarking
TABLE 181: U.S. Cataract Surgery Devices Market: Phacoemulsification Installed-Base Competitive Benchmarking
TABLE 182: U.S. Cataract Surgery Devices Market: Femtosecond Laser Competitive Benchmarking
TABLE 183: U.S. Cataract Surgery Devices Market: Digital Cataract Workflow Competitive Benchmarking
TABLE 184: U.S. Cataract Surgery Devices Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 185: Alcon Inc.: Company Profile
TABLE 186: Johnson & Johnson Surgical Vision: Company Profile
TABLE 187: Bausch + Lomb: Company Profile
TABLE 188: Carl Zeiss Meditec AG: Company Profile
TABLE 189: HOYA Surgical Optics: Company Profile
TABLE 190: Rayner: Company Profile
TABLE 191: RxSight, Inc.: Company Profile
TABLE 192: LENSAR, Inc.: Company Profile
TABLE 193: BVI Medical: Company Profile
TABLE 194: Glaukos Corporation: Company Profile
TABLE 195: Lenstec, Inc.: Company Profile
TABLE 196: HumanOptics AG: Company Profile
TABLE 197: OPHTEC: Company Profile
TABLE 198: Oertli Instrumente AG: Company Profile
TABLE 199: NIDEK CO., LTD.: Company Profile
TABLE 200: Ziemer Ophthalmic Systems AG: Company Profile
TABLE 201: Topcon Healthcare: Company Profile
TABLE 202: Haag-Streit Group: Company Profile
TABLE 203: Leica Microsystems: Company Profile
TABLE 204: Microsurgical Technology: Company Profile
TABLE 205: ASICO LLC: Company Profile
TABLE 206: Katena Products: Company Profile
TABLE 207: Diamatrix Ltd.: Company Profile
TABLE 208: Rhein Medical: Company Profile
TABLE 209: Corza Ophthalmology: Company Profile
TABLE 210: U.S. Cataract Surgery Devices Market: Future Market Scenario Analysis, 2026–2035
TABLE 211: U.S. Cataract Surgery Devices Market: Disruptive Technologies Impact Matrix
TABLE 212: U.S. Cataract Surgery Devices Market: Future Cataract Procedure Volume Outlook, 2026–2035
TABLE 213: U.S. Cataract Surgery Devices Market: Premium IOL Penetration Forecast, 2026–2035
TABLE 214: U.S. Cataract Surgery Devices Market: ASC Cataract Surgery Share Outlook, 2026–2035
TABLE 215: U.S. Cataract Surgery Devices Market: Cataract Equipment Replacement Cycle Outlook, 2026–2035
TABLE 216: U.S. Cataract Surgery Devices Market: Emerging Business Models
TABLE 217: U.S. Cataract Surgery Devices Market: High-Growth Product Opportunity Matrix
TABLE 218: U.S. Cataract Surgery Devices Market: State-Level Expansion Opportunity Matrix
TABLE 219: U.S. Cataract Surgery Devices Market: Investment Prioritization Matrix
TABLE 220: U.S. Cataract Surgery Devices Market: Strategic Recommendations for Device Manufacturers
TABLE 221: U.S. Cataract Surgery Devices Market: Strategic Recommendations for Ambulatory Surgery Centers
TABLE 222: U.S. Cataract Surgery Devices Market: Strategic Recommendations for Hospitals and Health Systems
TABLE 223: U.S. Cataract Surgery Devices Market: Strategic Recommendations for Ophthalmology Practices
TABLE 224: U.S. Cataract Surgery Devices Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 225: U.S. Cataract Surgery Devices Market: Strategic Recommendations for Distributors and Channel Partners
TABLE 226: U.S. Cataract Surgery Devices Market: Strategic Recommendations for New Entrants and Startups
TABLE 227: U.S. Cataract Surgery Devices Market: Go-to-Market Strategy Considerations
TABLE 228: U.S. Cataract Surgery Devices Market: Product Positioning and Portfolio Expansion Guidance
TABLE 229: U.S. Cataract Surgery Devices Market: State-Level Commercial Prioritization
TABLE 230: U.S. Cataract Surgery Devices Market: Surgeon Education and KOL Development Strategy
TABLE 231: U.S. Cataract Surgery Devices Market: Reimbursement and Market Access Strategy
TABLE 232: U.S. Cataract Surgery Devices Market: Scope Limitation
TABLE 233: U.S. Cataract Surgery Devices Market: Data Use Limitation
TABLE 234: U.S. Cataract Surgery Devices Market: Market Sizing Limitation
TABLE 235: U.S. Cataract Surgery Devices Market: Forecasting Limitation
TABLE 236: U.S. Cataract Surgery Devices Market: Procedure Volume Estimation Limitation
TABLE 237: U.S. Cataract Surgery Devices Market: State-Level Estimation Limitation
TABLE 238: U.S. Cataract Surgery Devices Market: Legal Disclaimer
TABLE 239: U.S. Cataract Surgery Devices Market: Third-Party Data Disclaimer

List of Figures

FIGURE 1: U.S. Cataract Surgery Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Market Sizing and Forecasting Framework
FIGURE 4: U.S. Cataract Surgery Devices Market Ecosystem
FIGURE 5: Stakeholder Ecosystem Analysis
FIGURE 6: Market Attractiveness Analysis
FIGURE 7: U.S. Cataract Surgery Devices Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 8: U.S. Cataract Surgery Devices Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 9: U.S. Cataract Surgery Devices Market Year-wise Growth Curve, 2021–2035
FIGURE 10: U.S. Cataract Procedure Volume Trend and Outlook
FIGURE 11: Premium IOL Penetration Trend
FIGURE 12: ASC Cataract Surgery Adoption Trend
FIGURE 13: U.S. Cataract Surgery Devices Market Dynamics
FIGURE 14: Drivers and Restraints Impact Matrix
FIGURE 15: Opportunities and Challenges Impact Matrix
FIGURE 16: Innovation & Patent Landscape, 2021–2025
FIGURE 17: Cataract Surgical Workflow Economics Framework
FIGURE 18: Premium IOL Patient Conversion Economics Framework
FIGURE 19: ASC Cataract Surgery Throughput Framework
FIGURE 20: Cataract Capital Procurement Decision Framework
FIGURE 21: Surgeon Preference and Vendor Standardization Framework
FIGURE 22: PESTEL Analysis
FIGURE 23: Porter’s Five Forces Analysis
FIGURE 24: Cataract Surgery Device Value Chain
FIGURE 25: Cataract Surgery Device Supply Chain
FIGURE 26: Cataract Device Pricing Trend, 2025–2035
FIGURE 27: ASC Versus Hospital Outpatient Cataract Economics
FIGURE 28: Ophthalmology Practice Consolidation Impact
FIGURE 29: Digital Cataract Surgical Workflow
FIGURE 30: FDA Regulatory and CMS Reimbursement Framework
FIGURE 31: Cataract Equipment Capital Replacement Cycle
FIGURE 32: Product Type Segment Market Share Analysis, 2025 & 2035
FIGURE 33: Product Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 34: Intraocular Lenses Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 35: Monofocal IOL Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 36: Toric IOL Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 37: Multifocal and Trifocal IOL Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 38: EDOF IOL Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 39: Adjustable IOL Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 40: Phacoemulsification Systems and Accessories Market Forecast, 2021–2035
FIGURE 41: Femtosecond Laser Cataract Systems Market Forecast, 2021–2035
FIGURE 42: OVDs, Procedure Packs and Surgical Consumables Market Forecast, 2021–2035
FIGURE 43: Surgery Type Segment Market Share Analysis, 2025 & 2035
FIGURE 44: Surgery Type Segment Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 45: Standard Phacoemulsification Cataract Surgery Market Forecast, 2021–2035
FIGURE 46: Laser-Assisted Cataract Surgery Market Forecast, 2021–2035
FIGURE 47: Premium Refractive Cataract Surgery Market Forecast, 2021–2035
FIGURE 48: Complex and Combined Cataract Surgery Opportunity Analysis
FIGURE 49: Technology Segment Market Share Analysis, 2025 & 2035
FIGURE 50: Technology Segment Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 51: Conventional Ultrasound Phaco Technology Market Outlook
FIGURE 52: Active-Fluidics and Intelligent Phaco Technology Adoption Roadmap
FIGURE 53: Femtosecond Laser Technology Adoption Outlook
FIGURE 54: Image-Guided Biometry and Surgical Navigation Growth Roadmap
FIGURE 55: AI-Assisted IOL Power Calculation Opportunity Map
FIGURE 56: Advanced IOL Optical Technology Opportunity Map
FIGURE 57: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 58: End User Segment Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 59: Ambulatory Surgery Center Cataract Device Demand Outlook
FIGURE 60: Hospital and Hospital Outpatient Cataract Device Demand Outlook
FIGURE 61: Ophthalmology Clinics and Physician-Owned Surgical Facilities Outlook
FIGURE 62: Academic and Tertiary Eye Center Market Outlook
FIGURE 63: Consolidated Ophthalmology Network Purchasing Framework
FIGURE 64: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 65: Regional Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 66: Regional Cataract Procedure Volume Opportunity Map
FIGURE 67: Regional Population Aged 65+ Cataract Demand Map
FIGURE 68: Regional ASC and Ophthalmology Infrastructure Map
FIGURE 69: Regional Premium IOL Adoption Opportunity Map
FIGURE 70: West Region U.S. Cataract Surgery Devices Market Share Analysis, 2025
FIGURE 71: West Region Market Share Analysis by State, 2025
FIGURE 72: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 73: California Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 74: Washington Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 75: Arizona Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 76: Colorado Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 77: Oregon Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 78: Utah Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 79: Nevada Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 80: New Mexico Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 81: Idaho Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 82: Montana Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 83: Wyoming Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 84: Alaska Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 85: Hawaii Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 86: Northeast Region U.S. Cataract Surgery Devices Market Share Analysis, 2025
FIGURE 87: Northeast Region Market Share Analysis by State, 2025
FIGURE 88: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 89: New York Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 90: Massachusetts Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 91: New Jersey Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 92: Pennsylvania Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 93: Connecticut Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 94: Maine Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 95: Vermont Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 96: New Hampshire Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 97: Rhode Island Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 98: Delaware Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 99: South Region U.S. Cataract Surgery Devices Market Share Analysis, 2025
FIGURE 100: South Region Market Share Analysis by State, 2025
FIGURE 101: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 102: Texas Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 103: Florida Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 104: Georgia Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 105: North Carolina Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 106: Tennessee Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 107: South Carolina Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 108: Alabama Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 109: Mississippi Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 110: Louisiana Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 111: Arkansas Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 112: Kentucky Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 113: Oklahoma Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 114: Virginia Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 115: Maryland Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 116: West Virginia Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 117: Midwest Region U.S. Cataract Surgery Devices Market Share Analysis, 2025
FIGURE 118: Midwest Region Market Share Analysis by State, 2025
FIGURE 119: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 120: Illinois Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 121: Ohio Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 122: Michigan Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 123: Minnesota Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 124: Indiana Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 125: Wisconsin Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 126: Missouri Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 127: Iowa Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 128: Kansas Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 129: Nebraska Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 130: North Dakota Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 131: South Dakota Cataract Surgery Devices Market Forecast, 2021–2035
FIGURE 132: U.S. Cataract Surgery Devices Market: Key Company Market Share Analysis, 2025
FIGURE 133: Company Positioning Matrix
FIGURE 134: Key Player Product Portfolio Benchmarking
FIGURE 135: Premium IOL Competitive Positioning Matrix
FIGURE 136: Phacoemulsification Installed-Base Competitive Landscape
FIGURE 137: Femtosecond Cataract Laser Competitive Landscape
FIGURE 138: Digital Cataract Workflow Competitive Landscape
FIGURE 139: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 140: U.S. Cataract Surgery Device Innovation Roadmap
FIGURE 141: Next-Generation Phaco Technology Roadmap
FIGURE 142: Premium IOL Technology Evolution Roadmap
FIGURE 143: Adjustable IOL Adoption Roadmap
FIGURE 144: AI-Assisted Cataract Surgery Opportunity Map
FIGURE 145: Future Market Scenario Analysis, 2026–2035
FIGURE 146: Disruptive Cataract Technologies Impact Matrix
FIGURE 147: Future Cataract Procedure Volume Outlook, 2026–2035
FIGURE 148: Premium IOL Penetration Roadmap, 2026–2035
FIGURE 149: ASC Cataract Surgery Migration Outlook, 2026–2035
FIGURE 150: Cataract Equipment Replacement Cycle Roadmap, 2026–2035
FIGURE 151: Emerging Cataract Surgery Business Models Matrix
FIGURE 152: High-Growth Product Opportunity Matrix
FIGURE 153: State-Level Expansion Opportunity Matrix
FIGURE 154: Investment Prioritization Matrix
FIGURE 155: Strategic Growth Roadmap for U.S. Cataract Surgery Device Companies
FIGURE 156: Go-to-Market Strategy Framework
FIGURE 157: Product Positioning and Portfolio Expansion Framework
FIGURE 158: State-Level Commercial Prioritization Framework
FIGURE 159: Surgeon Education and KOL Development Framework
FIGURE 160: Reimbursement and Market Access Strategy Framework
FIGURE 161: Report Scope, Market Sizing and Disclaimer Framework